Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 17856-0921

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 17856-0921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

17856 0921 01

17856 0921 01
Label for Sevelamer Carbonate 800 mg film coated tablets, oral use, distributed by Atlantic Biologicals Corp. The label states a package quantity of 100 tablets with storage instructions to keep at 20° to 25°C (68° to 77°F). It advises to see the package insert for indications and dosage schedule and includes a barcode and reorder phone number.*
FDA Label Image

Image Description (Sevelamer Fig1)

Image Description (Sevelamer Fig1)
A line graph showing the percentage of patients achieving specific reductions in serum phosphorus (mg/dL) on the X-axis versus the percentage of patients on the Y-axis. It compares the effects of Sevelamer Hydrochloride and an active control on serum phosphorus reduction and increase from baseline.*
FDA Label Image

Image Description (Sevelamer Fig2)

Image Description (Sevelamer Fig2)
A line graph titled 'Mean Phosphorus Change from Baseline for Patients who Completed 52 Weeks of Treatment' showing phosphorus change on the vertical axis and study weeks on the horizontal axis. It compares treatment with Sevelamer Hydrochloride versus an active control over 52 weeks, showing phosphorus reduction trends stabilizing around -2 to -3 units from baseline.*
FDA Label Image

Chemical Structure (Sevelamer Str)

Chemical Structure (Sevelamer Str)
Chemical structure diagram of Sevelamer Carbonate showing the polymer's extended network with labeled amine groups and crosslinking points. The diagram illustrates primary amine groups, crosslinking groups, and the polymeric nature of Sevelamer Carbonate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.